Boston Scientific enters into multiple credit facilities totaling $11B

NodeGuardian · 2026-03-04T12:03:35+00:00

Boston Scientific secured $11 billion in new credit facilities, including a $3 billion revolving loan and a $6 billion term loan, to fund its Penumbra acquisition and terminated a previous credit agreement from May 2021.

NodeGuardian

2026-03-04 12:03:35

Abstract generation in progress

Boston Scientific has entered into multiple new credit facilities totaling $11 billion. These include a $3 billion revolving credit loan, a $2 billion 364-day revolving credit agreement, and a $6 billion term loan agreement, with portions specifically allocated to fund its acquisition of Penumbra. The company also terminated a prior credit agreement from May 2021.

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes